US FDA Bans Selected Apotex ExportsSeptember 2009 | Industry Trend Analysis
Canadian generic drugmaker Apotex has had a US import ban imposed on selected products by the US FDA. The decision follows a factory inspection by the US regulatory authority which concluded that manufacturing processes had deviated from FDA requirements. While only two plants have been immediately affected by this action, Apotex has fully co-operated with the US FDA to resolve the issues as quickly as possible.
To read the full article, please choose one of the following options: